Host: |
Rabbit |
Applications: |
WB |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-Receptor-binding cancer antigen expressed on SiSo cells is suitable for use in Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
Concentration: |
1 mg/mL |
Dilution Range: |
WB 1:500-2000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
EBAG9 |
Gene ID: |
9166 |
Uniprot ID: |
RCAS1_HUMAN |
Specificity: |
This antibody detects endogenous levels of RCAS1 at Human, Mouse, Rat |
Immunogen: |
Synthesized peptide derived from human RCAS1 |
Function | May participate in suppression of cell proliferation and induces apoptotic cell death through activation of interleukin-1-beta converting enzyme (ICE)-like proteases. |
Protein Name | Receptor-Binding Cancer Antigen Expressed On Siso CellsCancer-Associated Surface Antigen Rcas1Estrogen Receptor-Binding Fragment-Associated Gene 9 Protein |
Database Links | Reactome: R-HSA-9018519 |
Cellular Localisation | Golgi Apparatus MembraneSingle-Pass Type Iii Membrane ProteinIt Also Exists As A Soluble Form Which Has The Same Biological ActivitiesThe Existence Of Such Soluble Form Is However Uncertain |
Alternative Antibody Names | Anti-Receptor-Binding Cancer Antigen Expressed On Siso Cells antibodyAnti-Cancer-Associated Surface Antigen Rcas1 antibodyAnti-Estrogen Receptor-Binding Fragment-Associated Gene 9 Protein antibodyAnti-EBAG9 antibodyAnti-RCAS1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance